Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries.

AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1281-5. Unique Identifier : AIDSLINE GENBANK/Y09780
Bibollet-Ruche F; Peeters M; Mboup S; Ekaza E; Gandji R; Torimiro J; Mpoudi EN; Amblard J; Dibanga G; Saidou M; Esu-Williams E; Vanden Haesevelde M; Saman E; Delaporte E; Project SIDAK, Laboratoire Retrovirus, ORSTOM, Montpellier,; France.

Keywords: JOURNAL ARTICLE Africa/EPIDEMIOLOGY Amino Acid Sequence DNA, Viral/ANALYSIS Human HIV Envelope Protein gp41/*GENETICS HIV Infections/EPIDEMIOLOGY/*VIROLOGY HIV-1/*CLASSIFICATION/*GENETICS Molecular Sequence Data Reverse Transcriptase Polymerase Chain Reaction RNA, Viral/ANALYSIS Serotyping Support, Non-U.S. Gov'tKWDjournalarticleafrica/epidemiologyaminoacidsequencedna,viral/analysishumanhivenvelopeproteingp41/KWDgeneticshivinfections/epidemiology/KWDvirologyhiv-1/KWDclassification/KWDgeneticsmolecularsequencedatareversetranscriptasepolymerasechainreactionrna,viral/analysisserotypingsupport,non-uKWDsKWDgov't
990228
A9920905

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .